Response to “Three drugs are unnecessary for treating paucibacillary leprosy—A critique of the WHO guidelines”

Open Access

Viewpoints are opinion pieces grounded in evidence on topics of broad interest to the journal's readership.

Bhushan Kumar,

Affiliation Consultant Dermatologist Shalby Hospital, SAS Nagar, Punjab
⨯
Vishal Thakur,

Affiliation Department of Dermatology, Venereology, and Leprology; Postgraduate Institute of Medical Education and Research, Chandigarh, India

http://orcid.org/0000-0003-0495-6571

⨯
Tarun Narang ,

* E-mail: narangtarun@yahoo.co.in

Affiliation Department of Dermatology, Venereology, and Leprology; Postgraduate Institute of Medical Education and Research, Chandigarh, India

http://orcid.org/0000-0002-0464-2989

⨯
Sunil Dogra

Affiliation Department of Dermatology, Venereology, and Leprology; Postgraduate Institute of Medical Education and Research, Chandigarh, India

http://orcid.org/0000-0001-9912-0085

⨯

Reader Comments (0)

Leprosy
Is the Subject Area "Leprosy" applicable to this article?

Thanks for your feedback.
Adverse reactions
Is the Subject Area "Adverse reactions" applicable to this article?

Thanks for your feedback.
Lesions
Is the Subject Area "Lesions" applicable to this article?

Thanks for your feedback.
Epidemiology
Is the Subject Area "Epidemiology" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Drug safety
Is the Subject Area "Drug safety" applicable to this article?

Thanks for your feedback.
Treatment guidelines
Is the Subject Area "Treatment guidelines" applicable to this article?

Thanks for your feedback.